Evident Vascular is an advanced intravascular ultrasound (IVUS) platform technology that leverages Artificial Intelligence (AI) and designed to deliver superior image interpretation and improved workflows

Independent consultant to Medical Device companies. Providing support in strategic planning, developing business plans, fund-raising and general corporate development activities. Currently supporting companies in cardiovascular, neurosurgical and women's health.

VytronUS is a clinical stage medical device company developing a next generation robotic ablation platform to treat atrial fibrillation and other cardiac arrhythmias. Assets acquired by . Completed transition and corporate dissolution.

Finance, Corporate and Business Development for early stage pioneer developer of Computer-Aided-Detection (AI Neural Net) software for 3D Breast Ultrasound screening systems.

Endosee Corp introduced the world's first single-use hysterscope for in-office hysteroscopy. Consulting CFO for Endosee Corp from inception thru successful exit. Managed multi-party sale process leading to acquisition by Cooper Surgical in October 2014.

Early-stage medical device company developing novel NIRS solutions for cerebral tissue monitoring.

Novel minimally invasive devices for the treatment of cardiac arrhythmias and instruments for cardiac surgery.

First FDA-approved Computer-Aided Detection (AI Neural Net) system in medical imaging. Initial application in mammography and currently standard of care.